About: Precaution Costs: The Presumption of Breast Cancer Seeding and Its Impact on Surgical Expenditure

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Precaution Costs: The Presumption of Breast Cancer Seeding and Its Impact on Surgical Expenditure Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Precaution Costs: The Presumption of Breast Cancer Seeding and Its Impact on Surgical Expenditure
Creator	Caudill, Antonina
source	Medline; PMC
abstract	As healthcare costs continue to rise at unsustainable rates (at an average rate of 5.5% a year), expenses without measurable outcomes need review.(1) In reconstructive surgery, empiric change of instruments between oncologic and reconstructive segments of surgery is one such practice. Breast surgery for ductal carcinoma in situ (DCIS), prophylaxis, and partial extirpation has little possible increase in seeding or implantation risk based on the literature. With undue extrapolation from higher risk cancers (such as ovarian), preventative practices of changing out trays, re-gloving, re-gowning, re-preparing, and re-draping between phases persist in operating rooms across the country. From real case costs, the additional expense of 2 surgical setups in the United States is conservatively estimated at $1232 per case, or over $125 million per year for this theoretical risk. Using implantation risk for core breast biopsies as a denominator, this cost is $1.65–$5.8 million per potential recurrence. This is an unacceptably high cost for hypothetical recurrence risk reduction, especially one that does not impact survival outcomes.
has issue date	2020-06-18(xsd:dateTime)
bibo:doi	10.1097/gox.0000000000002903
bibo:pmid	32766056
has license	cc-by-nc-nd
sha1sum (hex)	9ba2f805240df073cd7ae5c68ddb556fb5c28fd2
schema:url	https://doi.org/10.1097/gox.0000000000002903
resource representing a document's title	Precaution Costs: The Presumption of Breast Cancer Seeding and Its Impact on Surgical Expenditure
has PubMed Central identifier	PMC7339331
has PubMed identifier	32766056
schema:publication	Plast Reconstr Surg Glob Open
resource representing a document's body	covid:9ba2f805240df073cd7ae5c68ddb556fb5c28fd2#body_text
is schema:about of	named entity 'reconstructive surgery' named entity 'breast cancer' named entity 'lymph' named entity 'blood supply' named entity 'nosocomial infections' named entity 'morbidity' named entity 'breast reconstruction surgery' named entity 'tissue fluid' named entity 'Operating rooms' named entity 'betadine' named entity 'lobular carcinoma in situ' named entity 'healthcare industry' named entity 'surgical care' named entity 'mastectomies' named entity 'Centers for Medicare and Medicaid Services' named entity 'DCIS' named entity 'biopsy' named entity 'breast cancer' named entity 'tumor cells' named entity 'interstitial fluid' named entity 'Austria' named entity 'breast cancers' named entity 'tumor' named entity 'evidence-based medicine' named entity 'Joint Commission' named entity 'autologous' named entity 'tumor cells' named entity 'breast cancer' named entity 'prophylactic' named entity 'lumpectomies' named entity 'venous thromboembolism' named entity 'gynecomastia' named entity 'ductal carcinoma in situ' named entity 'breast cancer' named entity 'Ireland' named entity 'United States' named entity 'prophylactic' named entity 'microscope' named entity 'breast cancer' named entity '10,800' named entity 'mastectomy' named entity 'prospective studies' named entity '3, 4' named entity 'intraoperative' named entity 'neoplastic' named entity 'MBA' named entity 'United States' named entity '3.5' named entity 'breast cancer' named entity 'tumor' named entity 'breast reconstruction' named entity 'prophylactic' named entity 'risk based' named entity 'breast cancers' named entity 'neoplastic' named entity 'needle biopsy' named entity 'lobules' named entity 'breast surgery' named entity 'breast tissue' named entity 'prophylaxis' named entity 'prophylactic procedures' named entity 'American Cancer Society' named entity 'infection' named entity 'review article' named entity 'anatomical' named entity 'infection-control' named entity 'breast cancer' named entity 'tumor' named entity 'scientifically proven' named entity 'AORN' named entity 'oncologic' named entity 'aerosolization' named entity 'needle aspiration' named entity 'COVID-19 outbreak' named entity 'gross domestic product' named entity 'biopsies' named entity 'anesthesia' named entity 'epithelial cell' named entity 'infection' named entity 'quality-adjusted life year' named entity 'antibacterial'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software